Evidence map›Paper›PMID 36712988›Full record

ArticleFrontiers in chemistry2022

Rational design of potent ultrashort antimicrobial peptides with programmable assembly into nanostructured hydrogels.

Priscila Cardoso, Samuel Appiah Danso, Andrew Hung, Chaitali Dekiwadia, Nimish Pradhan, Jamie Strachan, Brody McDonald, Kate Firipis, Jacinta F White, Arturo Aburto-Medina and 2 more

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Synthesis and Biological Activity of Ultrashort Antimicrobial Peptides Bearing a Non-Coded Amino Acid.Journal of peptide science : an official publication of the European Peptide Society · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Priscila CardosoSchool of Health and Biomedical Sciences, Translational Immunology and Nanotechnology Theme, NanoBioPharm Research Group, RMIT University, Bundoora, VIC, Australia.
Samuel Appiah DansoSchool of Health and Biomedical Sciences, Translational Immunology and Nanotechnology Theme, NanoBioPharm Research Group, RMIT University, Bundoora, VIC, Australia.
Andrew HungSchool of Science, STEM College, RMIT University, Melbourne, VIC, Australia.
Chaitali DekiwadiaRMIT Microscopy and Microanalysis Facility (RMMF), RMIT University, Melbourne, VIC, Australia.
Nimish PradhanSchool of Health and Biomedical Sciences, Translational Immunology and Nanotechnology Theme, NanoBioPharm Research Group, RMIT University, Bundoora, VIC, Australia.
Jamie StrachanSchool of Health and Biomedical Sciences, Translational Immunology and Nanotechnology Theme, NanoBioPharm Research Group, RMIT University, Bundoora, VIC, Australia.
Brody McDonaldSchool of Health and Biomedical Sciences, Translational Immunology and Nanotechnology Theme, NanoBioPharm Research Group, RMIT University, Bundoora, VIC, Australia.
Kate FiripisBioFab3D, Aikenhead Centre for Medical Discovery, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia.
Jacinta F WhiteMaterials Characterisation and Modelling, Manufacturing, CSIRO, Clayton, VIC, Australia.
Arturo Aburto-MedinaSchool of Science, STEM College, RMIT University, Melbourne, VIC, Australia.
Charlotte E ConnSchool of Science, STEM College, RMIT University, Melbourne, VIC, Australia.
Céline ValérySchool of Health and Biomedical Sciences, Translational Immunology and Nanotechnology Theme, NanoBioPharm Research Group, RMIT University, Bundoora, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial resistance to common antibiotics is threatening to cause the next pandemic crisis. In this context, antimicrobial peptides (AMPs) are receiving increased attention as an alternative approach to the traditional small molecule antibiotics. Here, we report the bi-functional rational design of Fmoc-peptides as both antimicrobial and hydrogelator substances. The tetrapeptide Fmoc-WWRR-NH

Indexed as

antimicrobial peptide (AMP)fmoc-peptidesmolecular engineeringmolecular self assemblypeptide hydrogels

Identifiers

PMID36712988
PMCPMC9881724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.